Oncology research, 2019-09, Vol.27 (9), p.987-995
2019
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Nutlin-3-Induced Sensitization of Non-Small Cell Lung Cancer Stem Cells to Axitinib-Induced Apoptosis Through Repression of Akt1/Wnt Signaling
- Ist Teil von
- Oncology research, 2019-09, Vol.27 (9), p.987-995
- Ort / Verlag
- Elmsford, NY: Cognizant Communication Corporation
- Erscheinungsjahr
- 2019
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- The aim of this study was to investigate the potential biological activities of nutlin-3 in the regulation of growth and proliferation of non-small cell lung cancer (NSCLC) stem cells (CSCs), which may help in sensitizing to axitinib-induced apoptosis. Nutlin-3 induction of p53 expression was used to test its role in controlling the cell division pattern and apoptosis of NSCLC cells. A549 cells and H460 cells were pretreated with nutlin-3 and then treated with either an Akt1 activator or shRNA-GSK3β, to investigate the potential role of p53 sensitization in the biological effects of axitinib. We also determined the expression levels of GSK3β and p-Akt1 in patients with NSCLC and determined their potential association with survival data using Kaplan-Meier plots and CBIOTAL. Increased p53 expression stimulated the induction of apoptosis by axitinib and promoted asymmetric cell division (ACD) of NSCLC CSCs. The repression of Akt phosphorylation induced by nutlin-3 promoted the ACD of lung CSCs, decreasing the proportion of the stem cell population. In addition to the induction of apoptosis by axitinib through inhibition of Wnt signaling, nutlin-3 treatment further enhanced axitinib-induced apoptosis by inhibiting Akt1/GSK3β/Wnt signaling. The low expression of GSK3β and increased expression of p-Akt in patients with NSCLC were closely associated with the development of NSCLC. TP53 stimulates the induction of apoptosis in NSCLC by axitinib and the ACD of lung CSCs through its regulatory effects on the p53/Akt/GSK3β pathways.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0965-0407eISSN: 1555-3906DOI: 10.3727/096504018X15424918479652Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7848271
- Format
- –
- Schlagworte
- A549 Cells, Akt, Antineoplastic Combined Chemotherapy Protocols - pharmacology, Apoptosis, Apoptosis - drug effects, Asymmetric Cell Division (acd), Axitinib, Axitinib - administration & dosage, Axitinib - pharmacology, Cancer Stem Cells (cscs), Carcinoma, Non-Small-Cell Lung - drug therapy, Carcinoma, Non-Small-Cell Lung - metabolism, Carcinoma, Non-Small-Cell Lung - pathology, Cell Proliferation - drug effects, Drug Synergism, Humans, Imidazoles - administration & dosage, Imidazoles - pharmacology, Immunohistochemistry, Lung Neoplasms - drug therapy, Lung Neoplasms - metabolism, Lung Neoplasms - pathology, Non-Small Cell Lung Cancer (nsclc), Nutlin-3, Piperazines - administration & dosage, Piperazines - pharmacology, Proto-Oncogene Proteins c-akt - metabolism, Wnt Signaling, Wnt Signaling Pathway - drug effects